Medigene AG (MDGEF)
OTCMKTS · Delayed Price · Currency is USD
2.590
0.00 (0.00%)
Aug 24, 2025, 8:00 PM EDT
Medigene AG Market Cap
Medigene AG has a market cap or net worth of $1.12 million as of August 26, 2025. Its market cap has decreased by -97.05% in one year.
Market Cap
1.12M
Enterprise Value
-12.26M
Revenue
7.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.59
Market Cap Chart
Since June 30, 2000, Medigene AG's market cap has decreased from 438.84M to 1.12M, a decrease of -99.75%. That is a compound annual growth rate of -21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 1.09M | -93.03% |
| Dec 30, 2024 | 15.57M | -63.71% |
| Dec 29, 2023 | 42.90M | -20.29% |
| Dec 30, 2022 | 53.81M | -33.05% |
| Dec 30, 2021 | 80.37M | -24.67% |
| Dec 30, 2020 | 106.70M | -3.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 594.22M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |